There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial ...

Vektor Medical, a medical technology company transforming standard ECG data into actionable insights that guide arrhythmia ...

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial ...

UCLA researchers have successfully grown miniature lungs from stem cells—complete with their own functioning blood vessel ...

The decedent, who was obese and taking oral contraceptives, was not provided with mechanical deep vein thrombosis prophylaxis — specifically sequential compression devices — despite being at moderate ...

Targeted ablation guided by voltage mapping improved rhythm outcomes in individuals with recurrent atrial fibrillation after ...

BACKGROUND: Evaluation of whether dyspnea has a cardiac cause is essential. Guidelines from 2016 were reported to result in a ...

Abnormal filling in the pulmonary vein, identified as the pulmonary vein sign on computed tomography pulmonary angiography, is strongly associated with 30‐day deterioration in acute normotensive ...

Persistent pulmonary hypertension of the newborn (PPHN) is the most common neonatal form and mostly reversible after a few days with improvement of the underlying pulmonary condition. When pulmonary ...

Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days ...